← ACCENDRA HEALTH INC/VA/
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $108.8m | $72.8m | ($437.0m) | ($62.4m) | $29.9m | $221.6m | $22.4m | ($41.3m) | ($362.7m) | ($1.1b) | |
| Net Income (Loss) Available to Common Stockholders, Basic | $107.6m | $71.7m | ($437.0m) | — | — | — | — | — | — | — | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | — | ($1.1b) | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | — | ($22.6m) | $88.1m | $221.6m | $22.4m | $50.2m | $12.0m | ($102.7m) | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | $50.2m | $12.0m | ($102.7m) | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | $50.2m | $12.0m | ($998.0m) | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | — | — | — | ($39.8m) | ($58.2m) | $0 | $0 | $50.2m | $12.0m | ($998.0m) | |
| Depreciation, Depletion and Amortization | $55.4m | $59.4m | $101.9m | $116.7m | $93.3m | $90.6m | $228.7m | $287.4m | $264.8m | $214.5m | |
| Amortization of Intangible Assets | $10.0m | $16.4m | $36.5m | $44.0m | $41.5m | $39.8m | $78.8m | $83.5m | $64.9m | $74.0m | |
| Capitalized Computer Software, Amortization | $12.9m | $10.7m | $12.8m | $9.3m | $10.2m | $10.3m | $14.0m | $16.1m | $17.0m | — | |
| Depreciation | $55.4m | $32.3m | $42.9m | $43.5m | $41.5m | $40.5m | $136.0m | $188.0m | $183.0m | $214.5m | |
| Other Depreciation and Amortization | — | — | — | — | — | — | — | — | $13.0m | — | |
| Deferred Income Tax Expense (Benefit) | $4.2m | ($50.0m) | ($35.0m) | ($17.4m) | $15.6m | ($29.7m) | ($26.4m) | ($23.7m) | ($26.1m) | ($17.9m) | |
| Share-based Payment Arrangement, Noncash Expense | $12.0m | $11.9m | $16.4m | $15.8m | $20.0m | $25.0m | $21.0m | $23.2m | $26.8m | $12.9m | |
| Share-based Payment Arrangement, Expense | — | — | — | — | — | — | — | $23.2m | — | — | |
| Goodwill and Intangible Asset Impairment | — | — | $439.6m | $0 | — | — | — | — | — | — | |
| Goodwill, Impairment Loss | $0 | — | $423.1m | — | $0 | — | — | $0 | $307.1m | $0 | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | — | — | — | $32.1m | — | — | — | — | — | — | |
| Operating Lease, Impairment Loss | — | — | — | — | $4.9m | — | — | — | — | — | |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | — | — | — | — | — | — | — | — | $7.4m | — | |
| Gain (Loss) on Disposition of Business | — | — | — | — | ($65.5m) | $0 | $0 | — | — | — | |
| Gain (Loss) on Disposition of Property Plant Equipment | — | — | — | — | — | — | $26.3m | $34.9m | $44.7m | $27.3m | |
| Gain (Loss) on Extinguishment of Debt | $0 | — | — | $830k | $11.2m | ($40.4m) | $0 | $3.5m | ($1.1m) | — | |
| Income Tax Expense (Benefit) | $63.8m | ($15.3m) | ($32.2m) | ($6.1m) | $21.8m | $55.2m | ($11.5m) | ($13.4m) | $5.3m | $729k | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | — | $107.2m | |
| Other Nonoperating Income (Expense) | — | — | — | ($3.8m) | — | — | — | — | — | — | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Inventories | ($22.6m) | $57.0m | $65.5m | ($127.9m) | $85.2m | $263.4m | ($166.6m) | ($224.3m) | $26.2m | $6.9m | |
| Goodwill | $414.9m | $713.8m | $414.1m | $393.2m | $394.1m | $390.2m | $1.6b | $1.6b | $1.3b | $1.2b | |
| Nonoperating Income (Expense) | — | — | — | ($3.8m) | ($10.8m) | ($3.2m) | ($3.1m) | ($4.8m) | ($4.7m) | ($3.9m) | |
| Operating Costs and Expenses | — | — | — | — | — | — | — | — | — | $2.7b | |
| Payments of Financing Costs | $0 | $1.8m | $28.5m | $4.3m | $10.4m | $13.9m | $42.6m | $0 | $0 | — | |
| Proceeds from Stock Options Exercised | $0 | — | — | — | — | — | — | — | — | — | |
| Other Operating Income (Expense), Net | $7.4m | ($4.9m) | $4.4m | ($2.2m) | $2.4m | $6.2m | $5.3m | ($6.9m) | ($13.3m) | — | |
| Net Cash Provided by (Used in) Operating Activities | $186.9m | $56.8m | $115.6m | $166.1m | $339.2m | $124.2m | $325.0m | $740.7m | $161.5m | ($256.3m) | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $20.3m | $34.6m | $44.9m | $42.4m | $50.4m | $41.0m | $158.1m | $190.9m | $210.9m | $191.0m | |
| Payments to Acquire Businesses, Net of Cash Acquired | $0 | $366.6m | $751.8m | $0 | — | — | $1.7b | $0 | — | $18.1m | |
| Payments for (Proceeds from) Other Investing Activities | $0 | — | — | — | — | $3.9m | $1.7m | $936k | ($8.2m) | $1.9m | |
| Net Cash Provided by (Used in) Investing Activities | ($24.7m) | ($416.6m) | ($815.8m) | ($51.9m) | $80.1m | ($53.6m) | ($1.8b) | ($137.3m) | ($116.5m) | $144.4m | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Long-term Debt | $0 | $250.0m | $695.8m | $0 | $155.1m | — | — | — | — | — | |
| Repayments of Long-term Debt | $0 | $3.1m | $16.2m | $85.6m | $617.3m | $553.1m | $4.5m | $320.7m | $244.2m | — | |
| Proceeds from Issuance of Common Stock | — | — | — | — | $190.0m | $0 | $0 | — | — | — | |
| Payments for Repurchase of Common Stock | $71.0m | $5.0m | $0 | — | — | — | — | — | — | $10.2m | |
| Dividends paid | $63.4m | $63.2m | $48.2m | $5.2m | $648k | $731k | $0 | $0 | — | — | |
| Proceeds from (Payments for) Other Financing Activities | ($8.3m) | ($8.7m) | ($7.2m) | ($2.9m) | ($16.5m) | ($18.0m) | ($42.8m) | ($637k) | ($23.4m) | ($3.1m) | |
| Net Cash Provided by (Used in) Financing Activities | ($141.9m) | $272.8m | $701.1m | ($130.2m) | ($379.4m) | ($129.5m) | $1.5b | ($417.3m) | ($267.6m) | $188.1m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | ($2.0m) | ($2.7m) | $9.9m | ($3.5m) | ($3.5m) | $613k | ($901k) | $1.9m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | ($2.0m) | ($18.7m) | $49.8m | ($62.5m) | $14.2m | $186.7m | ($223.5m) | $232.6m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | ($2.0m) | $84.7m | $134.5m | $72.0m | $86.2m | $272.9m | $49.4m | $1.9m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | $68.6m | $95.4m | $90.0m | $38.7m | $107.0m | $153.2m | $141.5m | $134.7m | |
| Income Taxes Paid, Net | — | — | $19.2m | ($6.2m) | ($17.5m) | $99.4m | $34.0m | ($6.3m) | $5.6m | $12.5m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.